Evidence map›Paper›PMID 28327179›Full record

ArticleJournal of hematology & oncology2017

Pterostilbene prevents AKT-ERK axis-mediated polymerization of surface fibronectin on suspended lung cancer cells independently of apoptosis and suppresses metastasis.

Ying-Jan Wang, Jing-Fang Lin, Li-Hsin Cheng, Wen-Tsan Chang, Ying-Hsien Kao, Ming-Min Chang, Bour-Jr Wang, Hung-Chi Cheng

Open access · goldAbstract read
In one paragraph

Article in Journal of hematology & oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Anti-Stem Cell Property of Pterostilbene in Gastrointestinal Cancer Cells.International journal of molecular sciences · 2020
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. [Emerging Actions of Pterostilebene on Cancer Research].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ying-Jan WangDepartment of Environmental and Occupational Health, National Cheng Kung University, 1 University Road, 70101, Tainan, Taiwan.
Jing-Fang LinDepartment of Environmental and Occupational Health, National Cheng Kung University, 1 University Road, 70101, Tainan, Taiwan.
Li-Hsin ChengThe Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, 1 University Road, 70101, Tainan, Taiwan.
Wen-Tsan ChangThe Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, 1 University Road, 70101, Tainan, Taiwan.
Ying-Hsien KaoDepartment of Medical Research, E-Da Hospital, 82445, Kaohsiung, Taiwan.
Ming-Min ChangDepartment of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, 1 University Road, 70101, Tainan, Taiwan.
Bour-Jr WangDepartment of Environmental and Occupational Health, National Cheng Kung University, 1 University Road, 70101, Tainan, Taiwan.
Hung-Chi ChengThe Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, 1 University Road, 70101, Tainan, Taiwan. hungchi@mail.ncku.edu.tw.
National Cheng Kung University · TWChia Nan University of Pharmacy and Science · TWE-Da Hospital · TWTaipei Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPolymeric fibronectin (polyFN) assembled on suspended breast cancer cells is required for metastasis. Conceivably, drugs that target such polyFN may fight against cancer metastasis. While stilbene analogs trigger pro-apoptotic effect on attached cancer cells, whether they prevent polyFN assembly and metastasis of suspended cancer cells via an apoptosis-independent manner remains unexplored.

methodsWe depleted suspended Lewis lung carcinoma (LLC) cells of polyFN by silencing the endogenous FN expression or pterostilbene (PS) to examine whether metastasis of lung cancer cells could thus be suppressed. We investigated whether PS regulates AKT-ERK signaling axis to suppress polyFN assembly in suspended LLC cells independently of apoptosis. We tested the therapeutic effects of orally administered PS against cancer metastasis.

resultsBoth FN-silencing and PS among the three stilbenoids indeed significantly reduced polyFN assembly and lung metastasis of suspended LLC cells in an apoptosis-independent manner. Mechanistically, PS-induced AKT phosphorylation (pAKT) and suppressed ERK phosphorylation (pERK) in suspended LLC cells, whereas pretreatment with a PI3K inhibitor, LY294002, effectively reduced pAKT, rescued pERK, and consequently reversed the PS-suppressed polyFN assembly on LLC cells; these pretreatment effects were then overturned by the ERK inhibitor U0126. Indeed, PS-suppressed lung metastasis was counteracted by LY294002, which was further overruled with U0126. Finally, we found that PS, when orally administered in experimental metastasis assays, both significantly prevented lung colonization and metastasis of LLC cells and reduced the already established tumor growth in the mouse lungs.

conclusionsPS suppressed AKT/ERK-regulated polyFN assembly on suspended LLC cells and pulmonary metastasis. PS possesses potency in both preventing and treating lung metastasis of lung cancer cells in apoptosis-independent and apoptosis-dependent manners, respectively.

Indexed as

ApoptosisAnimalsCarcinoma, Lewis LungFibronectinsHumansLung NeoplasmsMAP Kinase Signaling SystemMiceNeoplasm MetastasisPolymerizationProto-Oncogene Proteins c-aktStilbenesFibronectinsProto-Oncogene Proteins c-aktpterostilbeneStilbenesFibronectinPericellular assemblyPI3K/AKT/ERK signalingPterostilbenePulmonary localization

Identifiers

PMID28327179
PMCPMC5361845
OpenAlexW2602736757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.